Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trial
Open Access
- 2 April 2025
- journal article
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (6) , 799-807
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation (ISRCAR00081)
This publication has 24 references indexed in Scilit:
- Documenting Race and Gender Biases in Pain Assessment and a Novel Intervention Designed to Reduce BiasesThe Journal of Pain, 2024
- Sex and gender differences in pain2022
- Use of Serratus Anterior Plane and Transversus Thoracis Plane Blocks for Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation Decreases Intraoperative Opioid RequirementsJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Analgesic Efficacy of Regional Anesthesia of the Hemithorax in Patients Undergoing Subcutaneous Implantable Cardioverter-Defibrillator PlacementJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantationHeart Rhythm, 2021
- Improving the care for female subcutaneous ICD patients: A qualitative study of gender-specific issuesInternational Journal of Cardiology, 2020
- Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testingAmerican Heart Journal, 2019
- Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter–defibrillatorsInternational Journal of Cardiology, 2018
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002